Header Logo

James Moy

Concepts (199)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
18
2021
161
2.180
Why?
Antibodies, Viral
6
2022
53
1.420
Why?
Immunoglobulin G
8
2022
95
1.360
Why?
Immunoglobulins, Intravenous
4
2018
19
0.970
Why?
Antibody Formation
2
2022
18
0.960
Why?
Salivary alpha-Amylases
1
2023
3
0.840
Why?
Vaccines
1
2022
7
0.820
Why?
Viral Vaccines
1
2022
2
0.820
Why?
Immunologic Deficiency Syndromes
3
2017
8
0.790
Why?
Agammaglobulinemia
2
2018
2
0.750
Why?
Common Variable Immunodeficiency
2
2018
4
0.750
Why?
Bacterial Infections
3
2018
52
0.720
Why?
Genetic Diseases, X-Linked
1
2018
1
0.600
Why?
Immunoglobulins
1
2017
20
0.570
Why?
Immunologic Factors
1
2017
34
0.560
Why?
Child, Preschool
12
2019
688
0.550
Why?
Immunotherapy
1
2017
56
0.550
Why?
Biomarkers
6
2023
596
0.540
Why?
Fluticasone
4
2019
5
0.510
Why?
Humans
39
2023
28436
0.510
Why?
Child
12
2021
1420
0.460
Why?
Adrenal Cortex Hormones
5
2019
117
0.440
Why?
Glucocorticoids
4
2019
70
0.430
Why?
Precision Medicine
3
2021
29
0.400
Why?
Respiratory Sounds
2
2019
9
0.380
Why?
Bronchodilator Agents
3
2019
21
0.360
Why?
Female
22
2021
15730
0.340
Why?
Male
21
2021
15291
0.340
Why?
Adolescent
9
2019
2307
0.340
Why?
Salmeterol Xinafoate
2
2019
3
0.330
Why?
Adult
13
2021
8107
0.330
Why?
Alendronate
2
2019
7
0.330
Why?
Ibuprofen
2
2021
12
0.320
Why?
NF-kappa B
3
2022
118
0.290
Why?
Double-Blind Method
9
2021
433
0.290
Why?
Saliva
2
2023
60
0.280
Why?
Middle Aged
10
2021
9269
0.280
Why?
Young Adult
6
2019
2069
0.280
Why?
Anti-Asthmatic Agents
4
2018
34
0.270
Why?
Administration, Inhalation
7
2019
45
0.260
Why?
Antibodies, Neutralizing
2
2022
19
0.250
Why?
Eosinophilia
2
2017
37
0.220
Why?
Respiratory Hypersensitivity
1
2003
2
0.220
Why?
Cockroaches
1
2003
2
0.220
Why?
Allergens
1
2003
16
0.220
Why?
Acetaminophen
3
2021
24
0.210
Why?
Nucleocapsid
1
2022
2
0.210
Why?
Neutralization Tests
1
2022
10
0.210
Why?
beta-Glucans
1
2022
24
0.200
Why?
Sputum
2
2019
21
0.200
Why?
Health Personnel
1
2022
107
0.190
Why?
Pandemics
2
2021
260
0.180
Why?
Immunity, Innate
1
2021
58
0.180
Why?
Infant
6
2018
587
0.180
Why?
Lung
2
2019
170
0.180
Why?
Prospective Studies
4
2019
1809
0.170
Why?
Cohort Studies
3
2021
1926
0.170
Why?
Adrenergic beta-2 Receptor Agonists
1
2019
4
0.170
Why?
Education, Medical, Continuing
1
2020
36
0.170
Why?
Hypersensitivity
1
2020
48
0.170
Why?
Tiotropium Bromide
1
2019
2
0.160
Why?
Mometasone Furoate
1
2019
8
0.160
Why?
Receptors, Adrenergic, beta-2
1
2019
3
0.160
Why?
Randomized Controlled Trials as Topic
1
2021
330
0.160
Why?
Betacoronavirus
1
2020
77
0.160
Why?
Vitamin A Deficiency
1
2018
1
0.160
Why?
Vitamin A
1
2018
8
0.160
Why?
Contrast Sensitivity
1
2018
7
0.160
Why?
Eosinophils
1
2019
47
0.160
Why?
Longitudinal Studies
1
2022
1384
0.150
Why?
Zinc
1
2018
47
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2018
21
0.150
Why?
Glutathione
1
2018
22
0.150
Why?
Arginine
1
2018
17
0.150
Why?
Coronavirus Infections
1
2020
90
0.150
Why?
Pneumonia, Viral
1
2020
94
0.150
Why?
HIV Infections
1
2022
488
0.140
Why?
Leukotriene Antagonists
1
2016
1
0.140
Why?
Inhalation Exposure
2
2008
5
0.130
Why?
Treatment Outcome
4
2018
3615
0.130
Why?
Sensitivity and Specificity
3
2022
517
0.130
Why?
Postoperative Complications
1
2022
932
0.130
Why?
Azithromycin
1
2015
2
0.130
Why?
Respiratory Tract Infections
1
2015
27
0.130
Why?
Secondary Prevention
1
2015
54
0.120
Why?
Research Design
3
2021
207
0.120
Why?
Pregnenediones
1
2014
3
0.120
Why?
Cholecalciferol
1
2014
6
0.110
Why?
Vitamins
1
2014
21
0.110
Why?
Vitamin D Deficiency
1
2014
11
0.110
Why?
Recurrence
3
2016
322
0.110
Why?
Anti-Bacterial Agents
1
2015
383
0.100
Why?
Cotinine
2
2011
5
0.100
Why?
Dose-Response Relationship, Drug
3
2019
351
0.100
Why?
Severity of Illness Index
3
2021
988
0.100
Why?
Quality of Life
1
2017
661
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2023
9
0.100
Why?
Dermatitis, Allergic Contact
1
2011
4
0.090
Why?
Pruritus
1
2011
9
0.090
Why?
Silicones
1
2011
11
0.090
Why?
Peritoneal Dialysis
1
2011
25
0.090
Why?
Catheters, Indwelling
1
2011
24
0.090
Why?
Mexican Americans
1
2011
29
0.090
Why?
Follow-Up Studies
3
2018
1859
0.090
Why?
Inflammation
2
2022
284
0.080
Why?
Smoking
1
2011
177
0.080
Why?
Prevalence
2
2018
468
0.080
Why?
Cross-Over Studies
2
2019
63
0.080
Why?
Aged
3
2018
9277
0.080
Why?
Tobacco Smoke Pollution
1
2008
7
0.080
Why?
Leukocyte Count
2
2019
66
0.070
Why?
Case-Control Studies
2
2021
594
0.070
Why?
Albuterol
2
2018
19
0.070
Why?
Models, Biological
1
2008
326
0.070
Why?
Cross-Sectional Studies
3
2018
933
0.060
Why?
Quinolines
1
2005
8
0.060
Why?
Acetates
1
2005
17
0.060
Why?
Incidence
2
2018
773
0.060
Why?
Air Pollution, Indoor
1
2003
2
0.060
Why?
Pyroglyphidae
1
2003
2
0.060
Why?
Skin Tests
1
2003
8
0.060
Why?
Cats
1
2003
30
0.050
Why?
Urban Health
1
2003
22
0.050
Why?
Child Welfare
1
2003
20
0.050
Why?
Statistics as Topic
1
2003
107
0.050
Why?
Dogs
1
2003
184
0.050
Why?
Signal Transduction
2
2022
447
0.050
Why?
Sialic Acid Binding Immunoglobulin-like Lectins
1
2023
3
0.050
Why?
Hepatitis B Antibodies
1
2022
1
0.050
Why?
Hepatitis B e Antigens
1
2022
1
0.050
Why?
Hepatitis B Surface Antigens
1
2022
6
0.050
Why?
Antibodies
1
2023
49
0.050
Why?
Killer Cells, Natural
1
2023
49
0.050
Why?
Syk Kinase
1
2022
10
0.050
Why?
Lectins, C-Type
1
2022
46
0.050
Why?
Respiratory Syncytial Viruses
1
2002
1
0.050
Why?
Chemokines
1
2002
21
0.050
Why?
Serologic Tests
1
2022
9
0.050
Why?
Clinical Trials, Phase II as Topic
1
2021
21
0.050
Why?
Advisory Committees
1
2021
25
0.050
Why?
Clinical Protocols
1
2021
60
0.050
Why?
Gene Expression Regulation, Neoplastic
1
2002
112
0.050
Why?
Immunization, Passive
1
2021
14
0.050
Why?
Seroepidemiologic Studies
1
2021
18
0.050
Why?
Immunoglobulin M
1
2021
16
0.050
Why?
Immunoglobulin Fc Fragments
1
2021
6
0.050
Why?
Receptors, Fc
1
2021
9
0.050
Why?
Complement Activation
1
2021
10
0.050
Why?
Antibody Specificity
1
2021
35
0.050
Why?
Spike Glycoprotein, Coronavirus
1
2021
17
0.050
Why?
Phagocytosis
1
2021
44
0.050
Why?
Tumor Necrosis Factor-alpha
1
2002
192
0.050
Why?
United States
2
2018
2201
0.050
Why?
Administration, Oral
2
2014
111
0.040
Why?
Education, Distance
1
2020
18
0.040
Why?
Drug Combinations
1
2019
36
0.040
Why?
Adrenergic beta-Antagonists
1
2019
29
0.040
Why?
Proof of Concept Study
1
2019
12
0.040
Why?
Reproducibility of Results
1
2021
737
0.040
Why?
Medication Adherence
1
2019
84
0.040
Why?
Ornithine
1
2018
1
0.040
Why?
Peak Expiratory Flow Rate
1
2018
1
0.040
Why?
Growth
1
2018
6
0.040
Why?
Surveys and Questionnaires
1
2003
1216
0.040
Why?
Analgesics, Non-Narcotic
1
2018
17
0.040
Why?
Tomography, X-Ray Computed
1
2021
730
0.040
Why?
Forced Expiratory Volume
1
2017
11
0.030
Why?
Immunoglobulin E
1
2017
11
0.030
Why?
Chicago
2
2011
946
0.030
Why?
Fever
1
2016
36
0.030
Why?
Neutrophils
1
2017
110
0.030
Why?
Kaplan-Meier Estimate
1
2016
179
0.030
Why?
Phenotype
1
2017
313
0.030
Why?
Animals
1
2003
3780
0.030
Why?
Drug Resistance, Bacterial
1
2015
53
0.030
Why?
Drug Administration Schedule
1
2015
166
0.030
Why?
Treatment Failure
1
2014
163
0.030
Why?
Disease Progression
1
2015
717
0.030
Why?
Pain
1
2016
405
0.030
Why?
Patch Tests
1
2011
2
0.020
Why?
Exanthema
1
2011
12
0.020
Why?
Morbidity
1
2011
58
0.020
Why?
Regression Analysis
1
2011
266
0.020
Why?
Drug Evaluation
1
2009
20
0.020
Why?
Half-Life
1
2009
12
0.020
Why?
Drug Dosage Calculations
1
2009
7
0.020
Why?
Kidney Failure, Chronic
1
2011
165
0.020
Why?
Socioeconomic Factors
1
2008
309
0.020
Why?
Sulfides
1
2005
11
0.020
Why?
Cyclopropanes
1
2005
15
0.020
Why?
Adrenergic beta-Agonists
1
2005
16
0.020
Why?
Placebos
1
2005
71
0.020
Why?
Acetylcysteine
1
2002
14
0.010
Why?
Free Radical Scavengers
1
2002
9
0.010
Why?
Tumor Cells, Cultured
1
2002
119
0.010
Why?
Oxidation-Reduction
1
2002
65
0.010
Why?
Dexamethasone
1
2002
35
0.010
Why?
Antiviral Agents
1
2002
71
0.010
Why?
Lung Neoplasms
1
2002
553
0.010
Why?
Moy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (199)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_